Clinical Management of Cavernous Malformations

Area of Science:

• Neuroscience
• Genetics
• Vascular Biology

Background:

• Cavernous malformations (CM) are vascular anomalies associated with significant morbidity, primarily due to hemorrhage.
• Identifying modifiable risk factors for CM-related hemorrhage remains a critical unmet need.
• Current management strategies involve weighing surgical risks against the natural history of the condition.

Purpose of the Study:

• To review the current epidemiology of cavernous malformations.
• To discuss the clinical management of patients diagnosed with CM.
• To explore recent advancements in understanding CM pathogenesis and potential therapeutic avenues.

Main Methods:

• Systematic literature review of epidemiological data on cavernous malformations.
• Analysis of clinical management guidelines and outcomes.
• Review of recent genetic and molecular research pertaining to CM.

Main Results:

• Hemorrhage is the most significant complication, leading to patient morbidity.
• Despite extensive research, no modifiable risk factors for preventing CM-related hemorrhage have been identified.
• The risk of recurrent hemorrhage is highest in patients with a history of prior clinical hemorrhages.
• Advances in understanding CCM gene functions (CCM1, CCM2, CCM3) have unveiled potential therapeutic targets.

Conclusions:

• Accurate estimation of hemorrhage risk is crucial for patient counseling and surgical decision-making.
• Future therapeutic strategies may target patients with a history of hemorrhage and high surgical risk.
• Ongoing research into the genetic underpinnings of CM holds promise for novel treatment development.